Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and In Vitro Validation.

This study represents a proof-of-concept for our hypothesis and a first step towards a truly targeted IBD treatment with cyclosporine that could be administered throughout the GI tract.
PMID: 32618133 [PubMed - as supplied by publisher]

Source: ChemMedChem - July 1, 2020 Category: Chemistry Authors: Manda JN, Markovic M, Zimmermann EM, Ben-Shabat S, Dahan A, Aponick A Tags: ChemMedChem Source Type: research